Immuno-oncology is set to become one of the most vital cancer treatments, rising up into the realms surgery, chemotherapy, radiotherapy, and other targeted therapies. From their study, “Pharma Focus Visual Analysis of Immuno-Oncology Development and Opportunities”, Global Data was able to reach a conclusion and has analyzed more than 4,000 clinical trials of over 800 […]
Continue readingTreatments against cancerous tumors have always been a dangerous and complicated process. These cancer cells can grow and spread rapidly. In addition, the current available treatments are determined by whether or not the patient can endure the treatment process, and also the location of the tumor. Scientists are now exploring Nano drugs. With the options […]
Continue readingThe study included oral and intravenous chemotherapy cancer drugs covered by Medicare Part B. Medicare is the federal health insurance plan for people 65 or older. “Higher costs lead to higher copays,” said study co-author Dr. Sham Mailankody. He’s a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. “And empiric research […]
Continue reading